Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-25T20:11:11.789Z Has data issue: false hasContentIssue false

Roadmap to engagement: Bringing patient partners into cancer research and beyond

Published online by Cambridge University Press:  02 August 2023

Kim S. Kimminau*
Affiliation:
Department of Family and Community Medicine, University of Missouri-Columbia, Columbia, MO, USA
Cheryl Jernigan
Affiliation:
University of Kansas Cancer Center, University of Kansas School of Medicine, Kansas City, KS, USA
Hope Krebill
Affiliation:
Masonic Cancer Alliance, Fairway, KS, USA
Sara Douglas
Affiliation:
Patient Advocacy and Engagement Talaris Therapeutics, Louisville, KY, USA
Jill Peltzer
Affiliation:
University of Kansas School of Nursing, Kansas City, KS, USA
Jill Hamilton-Reeves
Affiliation:
KU Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA
Ronald C. Chen
Affiliation:
Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA
Roy Jensen
Affiliation:
University of Kansas Cancer Center, University of Kansas School of Medicine, Kansas City, KS, USA
*
Corresponding author: K. S. Kimminau, PhD; Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

The University of Kansas Cancer Center (KU Cancer Center) initiated an engagement program to leverage the lived experience of individuals and families with cancer. KU Cancer Center faculty, staff, and patient partners built an infrastructure to achieve a patient-designed, patient-led, and research-informed engagement program called Patient and Investigator Voices Organizing Together (PIVOT). This special communication offers an engagement roadmap that can be replicated, scaled, and adopted at other cancer centers and academic health systems. PIVOT demonstrates that collaboration among academic leaders, investigators, and people with a lived experience yields a patient-centered, vibrant environment that enriches the research enterprise.

Type
Special Communications
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Association for Clinical and Translational Science

Introduction

Patient engagement improves the value of biomedical research and health care delivery [Reference Manafo, Petermann, Mason-Lai and Vandall-Walker1Reference Kim, Suarez-Cuervo and Berger7]. In terms of direct impact, integrating patients’ lived experiences has influenced patient-reported outcomes [Reference Barohn, Gajewski and Pasnoor8], shared decision-making tools [Reference Kanzaria, Booker-Vaughns and Itakura9], self-management care guidance [Reference Protheroe, Rogers, Kennedy, Macdonald and Lee10], health-quality of life metrics [Reference Haywood, Brett and Salek11], and many other aspects of research.

Even with requirements by funders, routinely designing and executing patient engagement in research has been elusive. A lack of infrastructure to address opportunities to improve patient-, caregiver-, and family-centered engagement drove the University of Kansas Cancer Center to create a solution designed to accelerate engagement and impact research. Although there have been models of engagement for various specific cancers [Reference Consolandi, Martini and Reni12Reference Hamad, Gore and Chisolm16], we found no published reports of an organized, system-level engagement infrastructure model to advance comprehensive patient engagement in research at academic cancer centers. NCI-designated cancer centers are charged with community engagement to create bidirectional relationships to inform research and services [Reference Paskett and Hiatt17]. The funding opportunity, released in 2016 (PAR-17-095) and reissued in 2020 (PAR 20-043), offers a springboard for developing an engagement roadmap at NCI-designated cancer centers. This special communication shares how the KU Cancer Center established a patient-driven program that meets the NCI-designated cancer center intent with a sustained infrastructure to conduct patient-centered, cancer research. We reasoned that modeling this in the context of the KU Cancer Center could offer a model for wider-scale adoption and be leveraged by KU’s clinical and translational science award program as well as in other institutes or centers, too.

Setting the Stage

The University of Kansas Cancer Center determined it would transform its culture to be more inclusive, with a deliberate focus on patient engagement. As described by Marlett et al, patient engagement is highly influenced by institutional ideology, as engagement with patients may be considered a challenge to professional expertise and expected role [Reference Marlett, Shklarov, Marshall, Santana and Wasylak18]. The process to develop PIVOT included research faculty, cancer center program staff, and patient research advocates approaching the center director to discuss their interest in developing an engagement program. Group discussions and brainstorming resulted in an initial plan that was presented and approved by the KU Cancer Center leadership team. The KU Cancer Center Director allocated funding for a start-up process that provided protected time for staff (Krebill) and center researcher (Kimminau), funds to remunerate patient partners as consultants (i.e., Jernigan), and funds to hire a half-time project manager (Douglas).

Establishing PIVOT

This roadmap was informed both by the experiences of the KU Cancer Center and by the emerging guidelines for effective patient engagement in research [Reference Kirwan, De Wit and Frank19]. To avoid tokenism [Reference Hahn, Hoffmann, Felzien, LeMaster, Xu and Fagnan20], the startup team included a lead patient advocate (Jernigan, KU) Cancer Center staff (Krebill), a lead researcher (Kimminau), and the project manager (Douglas). This team steered the initiation effort. They began by asking KU Cancer Center directors and physicians to identify potential patients, family members, and caregivers or local cancer advocates who they thought would be open to the idea of receiving training, co-developing training materials, working with investigators, and helping establish an engagement program. This intentionally avoided the startup process being dominated by any one cancer type. They also identified candidates from community leaders, community organizations (e.g., Gilda’s Club, local Komen Affiliate, etc.), community hospitals, and standing University of Kansas Medical Center community advisory boards (e.g. JUNTOS [Reference Cupertino, Saint-Elin and de Los Rios21], Faith Works [Reference Lumpkins, Philp, Nelson, Miller and Greiner22]). While not meant to mirror the KU Cancer Center’s patient demographic profile, the team invited individuals with attention to diversity accounting for race, ethnicity, socioeconomic status, geography (especially with respect to including rural participants), education attainment, and cancer type and cancer experience. Those selected formed the Patient Partner Development Team. The intent was to have this group establish the framework for PIVOT.

Fig. 1 provides an overview of PIVOT’s roadmap elements. The Patient Partner Development Team created the initial infrastructure for PIVOT. Once PIVOT was launched, PIVOT formed a revised Patient Leadership Team (PLT) to serve as a smaller decision-making group, led by the lead patient research advocate (Jernigan). The PLT determined PIVOT’s new member recruitment strategy; communication approaches including web, social media, and internal communication preferences; and education priorities/curriculum needed to level-set members’ knowledge about research generally and cancer research, specifically.

Figure 1. Patient and investigator voices organizing together (PIVOT) roadmap.

The lead patient research advocate chairs group meetings of the PLT. It is important for members to consistently see a patient in the primary leadership role. This demonstrates and reinforces the authenticity of commitment to patient voice and priorities driving PIVOT’s agenda and operation. Meetings happen during early evening hours to accommodate work schedules and other obligations. Members are paid hourly based on PCORI and other funder remuneration guidelines ($60/hour). Center staff and the lead researcher attend PLT meetings to assist in facilitation and manage minutes and tasks. Their presence also assisted in consistent communications with center leaders to offer updates, share needs, and discuss PLT suggested opportunities for collaboration.

The PLT discussed and then codified meeting norms and values (Table 1). These emerged from facilitated short, targeted strategic planning sessions. PIVOT members were eager to hear each other’’s perspectives, and the facilitator used appreciative inquiry [Reference Whitney and Cooperrider23,Reference Kaye Hart, Conklin and Allen24] to engage the group and achieve consensus.

Table 1. Patient and Investigator Voices Organizing Together (PIVOT) operating values and guidelines

PIVOT was established as a part of the community outreach and engagement efforts of the KU Cancer Center. To improve visibility, PIVOT developed a unique, complementary logo. An online service developed logo options within the visual context of the KU Cancer Center’’s brand identity, and the PLT voted to select the final version. Other examples of the Cancer Center’’s support of PIVOT communications include a dedicated PIVOT web page and the prominent display of PIVOT materials at KU Cancer Center-sponsored meetings.

The primary purpose of PIVOT is to promote patient engagement while serving as a resource for all cancer investigators to conduct patient-centered, patient-informed research. Fidelity to this purpose guided PIVOT’’s investment in research education. This crucial step in the roadmap is informed in the spirit of the Boot Camp Translation model [Reference Norman, Bennett and Cowart25,Reference Moody, Harris, Zittleman, Nease and Westfall26]. Patient partners shared that they needed tailored, plain language education to enable them to participate effectively and gain confidence to collaborate with researchers. The bootcamp’s aim is to strike a balance between covering enough basic and clinical science and research methodology to increase participants’ confidence, but not so much as to be overwhelming. PIVOT members helped to select bootcamp topics. PIVOT members also selected recruitment strategies to engage an ever-widening group of participants (Table 2). While the effort started on a relatively small scale (20 participants), each subsequent bootcamp increases PIVOT by an average of 25 new members. Since inception, more than 100 patients and family members have attended a PIVOT bootcamp (Table 3).

Table 2. PIVOT educational resources and training materials

Table 3. PIVOT research advocate demographics

RUCA codes are based on 2010 Rural-Urban Commuting Area Codes - 1, Metropolitan area core: primary flow within an urbanized area (UA); 2, Metropolitan area high commuting: primary flow 30% or more to a UA; 3, Metropolitan area low commuting: primary flow 10%–30% to a UA; 4, Micropolitan area core: primary flow within an Urban Cluster of 10,000 to 49,999 (large UC); 5, Micropolitan high commuting: primary flow 30% or more to a large UC.

We conducted four focus group sessions with 15 KU Cancer Center investigators from across the translational science spectrum to ask them about patient engagement in research. Not surprisingly, participants had varying levels of engagement experience. Most investigators reported they were more likely to engage patients after a study had begun. Mostly, they sought input about participant recruitment and retention. Generally, the investigators viewed patient engagement positively. However, they lacked an appreciation, particularly among those in the basic sciences, of the various ways patients could inform their research. Across all four focus groups, there was a lack of readiness for engagement. They shared that they and their colleagues do not have the time for engagement or for the engagement training they assumed was necessary to gain competency. Investigators were opposed to mandatory training because they felt it would be counterproductive and a barrier to facilitating engagement. Interestingly, focus group participants were more comfortable sharing what training should be required for patient research advocates, and how to acknowledge and compensate advocates for their contribution, than to identify their own training needs. PIVOT and KU Cancer Center leaders overestimated the readiness of researchers to become involved in patient-engaged research. Investigators’ assumptions that engagement takes too much time, patients would not be able to be helpful, and worries about slowing research processes dissuaded them from welcoming the opportunities PIVOT sought to offer.

PIVOT leaders decided to incrementally improve bidirectional engagement by developing the “Rapid Reactor Team” (RRT). The RRT is a way for researchers to spend time with bootcamp-trained PIVOT research advocates and reap engagement benefits in a short, one-hour design studio [Reference Joosten, Israel and Williams27]-styled session. PIVOT provides a blank, five PowerPoint slides template that the researcher is required to use to describe their study. PIVOT members interested in the topic volunteer to participate (eight to 10 participants maximum: ideally 5–7). The researcher submits their PowerPoint slides in advance to receive revision suggestions and coaching, usually on thinning their slide deck and on the need to use plain language. Ideally, revised slides are shared with the volunteer PIVOT members planning to attend the session. During the one-hour session, the researcher presents their slides for the first 10–15 minutes. After the presentation, the balance of the hour is reserved for PIVOT member reactions, questions, input, and discussion. The session is moderated by a facilitator to assist an effective bidirectional conversation that sometimes calls for research translation or the facilitator asking the researcher to restate or explain some element of their presentation to address a PIVOT member’s question more clearly. Each PIVOT participant is asked and encouraged to make comments, and they can follow-up with written comments after the session, too, if they prefer, with their input for the researcher.

An unanticipated benefit of the RRT model is that it proved to be an effective way to engage new PIVOT members. These sessions offer a low-stress, yet stimulating, way to learn about cancer research. Based on overwhelmingly positive reception, PIVOT added the RRT process into bootcamp training by providing case studies in a mock RRT format. This training gives bootcamp participants the chance to practice responding to research questions and to become familiar with the format.

To further strengthen RRT’s utility, researchers seeking a letter of support for their proposals from patients are encouraged to conduct an RRT session. This process allows PIVOT members to consider whether they agree to support an application. It also provides a way for the researcher to consider patient-informed modifications to their proposal. If the researcher seeks a patient collaborator to join their research team, the RRT group participants are asked first if they have an interest. Other PIVOT members can be identified to make a match based on lived experience and interest, and these individuals often also provide individual letters of support or commitment to participate. Financial support for the RRT PIVOT participants is provided at the same hourly rate as other PIVOT activities and is paid for with KU Cancer Center funding so it does not cost the researcher anything but their preparation and presentation time.

Process evaluation is emerging from the steady increase in the number of PIVOT participants and their duration of commitment to participate while maintaining the foundational commitment to diversity and some degree of balance across cancer types, cancer experience, and catchment area representativeness (Table 3).

Figure 2 displays RRT use by cancer center program demonstrating not only how positively the RRT has been received but also demonstrates the reach and value of patient engagement in various types of basic, clinical, and translational cancer research.

Figure 2. Use of PIVOT by KU Cancer Center investigators. CB = cancer biology; CPC = cancer prevention and control; D3ET=drug discovery, delivery, and experimental therapeutics.

More difficult to evaluate and measure is culture change stimulated by the establishment of PIVOT. Gaining momentum and shaping an engagement culture in a cancer center hinges on (1) moving along a continuum of increasing exposure and commitment and (2) working toward expanding the evidence that engagement impacts research outcomes [Reference Manafo, Petermann, Mason-Lai and Vandall-Walker1,Reference Anderson and McCleary28]. PIVOT exposure to the center’s research community began with PIVOT members simply attending the center’s annual scientific meeting without any specific accommodations. Over time, PIVOT members played increasingly visible and important roles at the conference (Table 4). This growth required intentional inclusion of engagement by leadership in both the planning and execution of the center’s events.

Table 4. Evolution of PIVOT engagement at annual KUCC meetings. (Table displays year on year additive activities.)

Ongoing outcomes evaluation is planned to track the success of research applications that used PIVOT resources, recommendations, and experts; the successful resubmission of applications; and the ongoing connectivity between individual PIVOT research advocates and academic research teams. Impact evaluation to focus on long-term, sustained changes in the KU Cancer Center, will continue to monitor uptake from the novelty of PIVOT to the routine expectation that PIVOT input and collaboration are essential to the center’s success.

Summary

Patient engagement must be tailored and responsive to the needs of patients [Reference James29Reference Jerofke-Owen and Garnier-Villarreal32]. As expectations for patient engagement increase, risks of tokenism and even greater marginalization of underrepresented patients increase. Furthermore, engagement is influenced by institutional ideologies, professional attitudes, and patient readiness [Reference Marlett, Shklarov, Marshall, Santana and Wasylak18]. Reducing risks of failure requires intentionality and planning [Reference Bombak and Hanson33]. Overcoming risk factors requires sensitivity to constructing a roadmap that accounts for multiple, simultaneous constraints and opportunities. Engagement and genuine support from senior leadership are essential for both growth and sustainability of a program. This roadmap was not determined a priori, but instead, it evolved over time through learning what was effective, what patient partners needed, and how to best meet the needs of the cancer research community.

Five resources and skills are essential to pursue the milestones of this roadmap. This list is transferrable to other engagement startup efforts important to other cancer centers, Clinical and Translational Science awardees, and other academic health centers that intend to establish a durable, patient-led, and informed platform designed to be a resource for collaboration.

  1. 1. Deploying staff who have program implementation expertise, operational oversight experience, and understanding of the mechanisms to initiate a startup program was crucial. Staff must be able to relate to patients in ways that ensure they feel valuable and recognized for their contributions every time they interact with the program.

  2. 2. Having a seasoned patient research advocate with experience in leading initiatives and modeling behaviors for newer patient research advocates was critical. An added benefit was this patient leadership model helped attract additional PIVOT members with experience in engagement. This substantially expanded PIVOT’s leadership capacity.

  3. 3. Coaching skills are essential. Coaching and appreciation for adult learning styles offered ways to help patients adjust their behavior to interact effectively in a new role with clinicians and clinical researchers. Coaching offers a dual advantage of (1) assisting in communication and interaction skills for the research advocate, and (2) helping investigators feel less intimidated working directly with patients. For some investigators, exposure to PIVOT members was their first experience talking with someone with a lived experience in the cancer they study.

  4. 4. Conducting an environmental scan to find researchers engaged with patient and community partners did not yield substantially new information for PIVOT. However, this step is recommended to ensure current structures are accounted for when developing the model. Also, it is wise to be aware of academic boundaries and biases that may exist among engagement faculty and target communities in advance of initiating the program [Reference Kimminau, Jernigan and LeMaster34].

  5. 5. The entire engagement enterprise requires high touch, humanistic, and skilled facilitation with particular attention to having someone who can distill technical information effectively for non-researchers. Having someone who excels in science communications is invaluable.

Launching an engagement program requires committed leadership. While no memorandum of understanding was established, it was the center’s director who found the case for PIVOT compelling and supported it with resources. He also used his influence to elevate awareness and persuade investigators to utilize PIVOT to bring their own creative ideas and challenging research problems to the group. The commitment to dedicated staffing, sustainable funding, and intentional training programing strengthened the capabilities of patient partner(s) and collaborating researchers to engage. The result so far is a vibrant and impactful program that enhances the quality and patient relevance of the cancer center’s research agenda and outcomes.

Acknowledgments

Patient and Investigator Voices Organizing Together (PIVOT) was constructed through the efforts of founding and current members. Among many, we especially thank these PIVOT members (in alphabetical order): Becky Burns, Broderick Crawford, Julie Crotts, Kent Culbertson, Kristine Darnell, Ashley Flynn, Karl Frees, Tim Grimes, Peggy Johnson, Kim Jones, Jennie Mack, Brian Manning, Sylvia H. Smith, Tracy Mason Solis, Donielle Potts, Paul Wagle, and other members of the PLT for their visionary leadership, persistence, patience, and enormous dedication in helping the KU Cancer Center establish this collaborative patient-driven, patient-centered, and patient-led engagement model. Others who made space offered support and engaged in this effort on behalf of the University of Kansas Cancer Center include Drs. Carol Fabian, Dan Dixon, Scott Weir, Matthew Mayo, Andrew Godwin, Kristi Neufeld, and Danny Welch. We offer special appreciation to the inaugural PIVOT project manager, Danielle Peereboom. Thanks to Claudia Johnson at MU Health Care for drafting the figure.

Funding statement

This work was supported by NCI and NIH grant numbers P30CA168524, P30CA168524-08S1, 3P30CA168524-09S2, 3P30CA168524-09S4, 5P20GM130423-03, and 1UG1CA239767.

Competing interests

The authors have no conflicts of interest to declare.

References

Manafo, E, Petermann, L, Mason-Lai, P, Vandall-Walker, V. Patient engagement in Canada: a scoping review of the ‘how’and ‘what’of patient engagement in health research. Health Res Policy Syst. 2018;16(1):111.Google Scholar
Liang, L, Cako, A, Urquhart, R, et al. Patient engagement in hospital health service planning and improvement: a scoping review. BMJ Open. 2018;8(1):e018263.CrossRefGoogle ScholarPubMed
Sharma, AE, Rivadeneira, NA, Barr-Walker, J, Stern, RJ, Johnson, AK, Sarkar, U. Patient engagement in health care safety: an overview of mixed-quality evidence. Health Affairs. 2018;37(11):18131820.CrossRefGoogle ScholarPubMed
Sharma, AE, Knox, M, Mleczko, VL, Olayiwola, JN. The impact of patient advisors on healthcare outcomes: a systematic review. BMC Health Serv Res. 2017;17(1):114.CrossRefGoogle ScholarPubMed
Fergusson, D, Monfaredi, Z, Pussegoda, K, et al. The prevalence of patient engagement in published trials: a systematic review. Res Involv Engagem. 2018;4(1):19.CrossRefGoogle ScholarPubMed
Forsythe, LP, Carman, KL, Szydlowski, V, et al. Patient engagement in research: early findings from the patient-centered outcomes research institute. Health Aff. 2019;38(3):359367.CrossRefGoogle ScholarPubMed
Kim, JM, Suarez-Cuervo, C, Berger, Z, et al. Evaluation of patient and family engagement strategies to improve medication safety. The Patient-Center Outcomes Res. 2018;11(2):193206.CrossRefGoogle ScholarPubMed
Barohn, RJ, Gajewski, B, Pasnoor, M, et al. Patient assisted intervention for neuropathy: comparison of treatment in real life situations (PAIN-CONTRoLS): Bayesian adaptive comparative effectiveness randomized trial. JAMA Neurol. 2021;78(1):6876.CrossRefGoogle ScholarPubMed
Kanzaria, HK, Booker-Vaughns, J, Itakura, K, et al. Dissemination and implementation of shared decision making into clinical practice: a research agenda. Acad Emerg Med. 2016;23(12):13681379.CrossRefGoogle ScholarPubMed
Protheroe, J, Rogers, A, Kennedy, AP, Macdonald, W, Lee, V. Promoting patient engagement with self-management support information: a qualitative meta-synthesis of processes influencing uptake. Implement Sci. 2008;3(1):112.CrossRefGoogle ScholarPubMed
Haywood, K, Brett, J, Salek, S, et al. Patient and public engagement in health-related quality of life and patient-reported outcomes research: what is important and why should we care? Findings from the first ISOQOL patient engagement symposium. Qual Life Res. 2015;24(5):10691076.CrossRefGoogle ScholarPubMed
Consolandi, M, Martini, C, Reni, M, et al. COMMUNI. CARE (COMMUNIcation and patient engagement at diagnosis of PAncreatic CAncer): study protocol. Front Med. 2020;7:134.CrossRefGoogle ScholarPubMed
Fitch, MI. The changing face of lung cancer: survivor perspectives on patient engagement. Asia-Pac J Oncol Nurs. 2019;6(1):1723.CrossRefGoogle ScholarPubMed
Wagle, N, Painter, C, Anastasio, E, et al. The Metastatic Breast Cancer (MBC) project: Accelerating Translational Research Through Direct Patient Engagement. American Society of Clinical Oncology; 2017.Google Scholar
Iwata, AJ, Olden, HA, Kippen, KE, Swegal, WC, Johnson, CC, Chang, SS. Flexible model for patient engagement: achieving quality outcomes and building a research agenda for head and neck cancer. Head Neck. 2019;41(4):10871093.CrossRefGoogle ScholarPubMed
Hamad, J, Gore, J, Chisolm, S, et al. Patient empowerment through engagement in bladder cancer research. Elsevier. 2021;193(3):e13193, e19.Google Scholar
Paskett, ED, Hiatt, RA. Catchment areas and community outreach and engagement: the new mandate for NCI-designated cancer centers. Cancer Epidemiol Prev Biomarkers. 2018;27(5):517519.CrossRefGoogle ScholarPubMed
Marlett, N, Shklarov, S, Marshall, D, Santana, MJ, Wasylak, T. Building new roles and relationships in research: a model of patient engagement research. Qual Life Res. 2015;24(5):10571067.CrossRefGoogle Scholar
Kirwan, JR, De Wit, M, Frank, L, et al. Emerging guidelines for patient engagement in research. Valu Health. 2017;20(3):481486.CrossRefGoogle ScholarPubMed
Hahn, DL, Hoffmann, AE, Felzien, M, LeMaster, JW, Xu, J, Fagnan, LJ. Tokenism in patient engagement. Fam Pract. 2017;34(3):290295.Google ScholarPubMed
Cupertino, AP, Saint-Elin, M, de Los Rios, JB, et al. Empowering promotores de salud as partners in cancer education and research in rural Southwest Kansas. NIH Public Access. 2015;42(1):1522.Google Scholar
Lumpkins, CY, Philp, A, Nelson, KL, Miller, LM, Greiner, KA. A road map for the future: an exploration of attitudes, perceptions, and beliefs among African Americans to tailor health promotion of cancer-related genetic counseling and testing. J Genet Couns. 2020;29(4):518529.CrossRefGoogle ScholarPubMed
Whitney, D, Cooperrider, D. Appreciative inquiry: A positive revolution in change. San Francisco, CA: Berrett-Koehler Publishers, 2011.Google Scholar
Kaye Hart, R, Conklin, TA, Allen, SJ. Individual leader development: an appreciative inquiry approach. Adv Dev Hum Resour. 2008;10(5):632650.CrossRefGoogle Scholar
Norman, N, Bennett, C, Cowart, S, et al. Boot camp translation: a method for building a community of solution. J Am Board Fam Med. 2013;26(3):254263.CrossRefGoogle ScholarPubMed
Moody, EJ, Harris, B, Zittleman, L, Nease, DE Jr, Westfall, JM. It’s time for a change!: the appreciative inquiry/bootcamp translation to address disparities in the latino community with autism spectrum disorders. Cultur Div Ethnic Minor Psychol. 2019;25(1):113.CrossRefGoogle ScholarPubMed
Joosten, YA, Israel, TL, Williams, NA, et al. Community engagement studios: a structured approach to obtaining meaningful input from stakeholders to inform research. Acad Med. 2015;90(12):16461650.CrossRefGoogle ScholarPubMed
Anderson, M, McCleary, KK. On the path to a science of patient input. Sci Transl Med. 2016;8(336):336ps11.CrossRefGoogle ScholarPubMed
James, J. Patient engagement. Health Aff Health Policy Brief. 2013;14(10.1377).Google Scholar
Coulter, A. Patient engagement—what works? J Ambul Care Manage. 2012;35(2):8089.CrossRefGoogle ScholarPubMed
Faulkner, SD, Sayuri Ii, S, Pakarinen, C, et al. Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: a mixed-methods study. Health Expect. 2021;24(2):601616.CrossRefGoogle Scholar
Jerofke-Owen, TA, Garnier-Villarreal, M. Development and psychometric analysis of the patient preferences for engagement tool. Nurs Res. 2020;69(4):289298.CrossRefGoogle ScholarPubMed
Bombak, AE, Hanson, HM. A critical discussion of patient engagement in research. J Patient Cent Res Rev, 2017;4(1):3941.CrossRefGoogle ScholarPubMed
Kimminau, KS, Jernigan, C, LeMaster, J, et al. Patient vs. community engagement: emerging issues. Med Care. 2018;56(10 Suppl 1):S53S57.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1. Patient and investigator voices organizing together (PIVOT) roadmap.

Figure 1

Table 1. Patient and Investigator Voices Organizing Together (PIVOT) operating values and guidelines

Figure 2

Table 2. PIVOT educational resources and training materials

Figure 3

Table 3. PIVOT research advocate demographics

Figure 4

Figure 2. Use of PIVOT by KU Cancer Center investigators. CB = cancer biology; CPC = cancer prevention and control; D3ET=drug discovery, delivery, and experimental therapeutics.

Figure 5

Table 4. Evolution of PIVOT engagement at annual KUCC meetings. (Table displays year on year additive activities.)